ExpreS²ion VP of Preclinical Development Mette Thorn and CFO Keith Alexander will provide an update on ExpreS²ion’s HER2+ therapeutic breast cancer vaccine program and answer participants’ questions. More information and registration can be found on the H.C. Andersen Capital events website.